Five Star Equities Provides Stock Research on BG Medicine and YM BioSciences
Continue ReadingTag: five-star-equities
Merger and Acquisition Activity Expected to Rise in 2013 as Big Pharma Companies Flush With Cash
Five Star Equities Provides Stock Research on ImmunoGen and InterMune
Continue Reading
U.S. Housing Market Recovery Continues as Prices in November Post Largest Gains in 6 and 1/2 Years
Five Star Equities Provides Stock Research on Hovnanian Enterprises and Standard Pacific
Continue Reading
Record Levels of Available Cash and Moderate R&D Development Will See Big Pharma M&A Activity Increase in 2013
Five Star Equities Provides Stock Research on Ariad Pharmaceuticals and PDL BioPharma
Continue Reading
U.S. Oil Production Hits Highest Level in 20 Years, Projected to Increase an Additional 14% in 2013
Five Star Equities Provides Stock Research on Baker Hughes and Halliburton
Continue Reading
Mergers and Acquisitions Within the Biotech Industry Expected to Rise in 2013
Five Star Equities Provides Stock Research on Lexicon Pharmaceuticals and NPS Pharmaceuticals
Continue Reading
Biotech Industry Expected to Experience More M&A Activity in 2013
Five Star Equities Provides Stock Research on Aastrom Biosciences and Exelixis
Continue Reading
Oil & Gas Services Industry Look to Benefit as Domestic Oil Production Shows No Sign of Slowing Down
Five Star Equities Provides Stock Research on National-Oilwell Varco and Weatherford International
Continue Reading
Major Revenue Losses From Patent Expirations Forces Big Pharma Companies to Look to the Biotech Industry for Replacements
Five Star Equities Provides Stock Research on CEL-SCI and ImmunoCellular
Continue Reading
U.S. Oil Production Hits Highest Level in 20 Years, Projected to Increase an Additional 14% in 2013
Five Star Equities Provides Stock Research on Key Energy Services and Nabors Industries
Continue Reading